All News

Prevalence of abnormal SI joint findings on MRE and MRI is 25% in Crohn's pts. Majority didn't report back pain, were female, and had intestinal complications of CD. Abs 1306 #ACR21 #RheumNow @RheumNow https://t.co/LOGoxAfrQi https://t.co/qAKC8GCLno

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Abst1005 #ACR21 #ACRBest @RheumNow study identifies monocyte-derived DC population characterized as CD209+/CD14+ DC in the synovium of RA and PsA patients sensitive to JAK/STAT, but not TNF inhibition.

Olga Petryna DrPetryna ( View Tweet)

VACOLUP study: COVID19 vacc, 1189 SLE pts 👉No sig. diff based on gender, age, nor type of vax 👉3.2% pts w/SLE flare 👉Flares mainly fatigue and MSK symptoms (SLE flare or side-effect of the vac?) https://t.co/w5dYsLkk5D #ACR21 Abst#1421 @RheumNow #ACRBest

Links:

Pedro Castillo _Castillo_Pedro ( View Tweet)

Dr Keen presenting on GCA admitted to hospital. Propensity score matched to non-GCA population. Increased all cause mortality compared to general population in Western Australia (aHR 1.13). Most pronounced in early years after diagnosis. Abstr#1393 #ACR21 @RheumNow https://t.co/laW8mxp6uq
Richard Conway RichardPAConway ( View Tweet)
Dr Björn Bühring highlights the burden of #multimorbidity and particularly #sarcopenia in older patients with #rheumatoidarthritis. #ACR21 @RheumNow https://t.co/3xGtx48DAU
Mrinalini Dey DrMiniDey ( View Tweet)
Majority of rheum pts on csDMARDs, TNFi, JAKi & TCZ had adequate serologic response to m-RNA based vaccines. Poor vaccine reactivity mainly assoc'd w/ RTX, steroids, and MMF. Study did not include ABA. Abs 1087 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/q4C66Htz5a https://t.co/MS7cqdFWBi

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Abst1083 #acr21 #ACRBest @RheumNow study of COVID-19 outcomes in pts w/systemic auto inflammatory disease:31% had a flare of underlying SAID, either concurrently (20%) or after recovering from COVID-19 (11%). The majority of SAID pts w/COVID-19 reported mild to moderate illness https://t.co/qzYfmYpA25
Olga Petryna DrPetryna ( View Tweet)
Important to properly assess #sarcopenia in older patients with #RA. Useful tools include: 👉🏼SARC-F questionnaire (≥ 4 is abnormal) 👉🏼Muscle function tests incl Short Physical Performance Battery #ACR21 @RheumNow https://t.co/9l6b7tJ1xC
Mrinalini Dey DrMiniDey ( View Tweet)
Retrospective French case study showed PAH is rare but potentially severe complication of AOSD. In this trial of 13, it only affected women. Further studies needed! Abs 1100 #ACR21 #RheumNow @RheumNow https://t.co/6CufqRV0Qg https://t.co/h73mxsJswi

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Abst1094 #acr21 @RheumNow rheum pts and extremely ⬆️ESR: infection vs flare: Thrombocyte, MCV, albumin and total protein were significantly lower in infection group, however; neutrophil, MPV, CRP and ferritin were significantly lower in flare-up group https://t.co/C6MQo86Ljb
Olga Petryna DrPetryna ( View Tweet)
Urinary CD163: Potential Biomarker in LN 💠Correlated w/histological activity 💠⬆️in prolif LN 💠⬇️in responders 💠Clinical features + biomarkers may provide non-invasive method to dx and monitor response in LN https://t.co/u910ehQH74 #ACR2021 Abst#1422 @RheumNow #ACRBest

Links:

Pedro Castillo _Castillo_Pedro ( View Tweet)

TCZ in COVID-19: studies that form the basis of the EUA, direct from the @US_FDA (now can we have enough for our RA, GCA, and JIA pts still on it, please @genentech @Roche?) #ACR21 FDA update @RheumNow https://t.co/ZQv9XtoRJZ
David Liew drdavidliew ( View Tweet)
“Geriatrics is a team sport!” – Dr. Buehring #ACR11 @rheumnow @UnaMakris #GeriRheum #aging https://t.co/ckAJsi696Y
TheDaoIndex KDAO2011 ( View Tweet)
#ACR21 #Abstr Are we close to not needing kidney biopsy to assess #lupus nephritis? A study showed Urinary CD163: ⬆️in proliferating LN ⬇️in responders with good AUC Further works: ?marker for flare, how sensitive vs uPCR, different therapies @RheumNow https://t.co/d0quh9wu5h https://t.co/zWm8SJvRXz

Links:

Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)

Hip involvement/TJR assoc'd w/ MEFV+ vs HLA-B27+ in FMF/SpA pts vs SpA. FMF/SpA: more severe disease, worse outcomes, & destructive hip involvement vs SpA, particularly in pts with MEFV variants & M694V homozygosity. Abs 1108 #ACR21 #RheumNow @RheumNow https://t.co/hlnN26AYgE https://t.co/1jHeVxKs7O

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Very interesting talks by @UnaMakris and #DrBuhring on Multicomplexity in the Aging Patient with #RA #ACR21 @RheumNow https://t.co/WA8YtEpKhk
Akhil Sood MD AkhilSoodMD ( View Tweet)
Open label study of only 8 weeks of steroid with tocilizumab for 1 year in GCA. 74% sustained steroid free remission at 1 year. Wow! Needs an RCT. Abstr#1413 #ACR21 @RheumNow https://t.co/c82qGJCFip
Richard Conway RichardPAConway ( View Tweet)
“NSAIDS are not off the table for older adults!” – Dr @unamakris says use⬇️dose &monitor; GFR may be misleading (toxicity seen w/normal Cr) She’s not a fan of tramadol, but recc topical pain meds, SSRI/NSRI, short-acting⬇️dose opioids when acet & nonpharm Rx fail @rheumnow #ACR21 https://t.co/rLeEagwrQU
TheDaoIndex KDAO2011 ( View Tweet)
KOA can not only ⬆️ morbidity, it also ⬆️s mortality - long term data from OAI - 5K pts, f/u 9 yrs . Greater KL scores (worse Xrays) - greater mortality! #ACR21 abst#1028 @RheumNow https://t.co/jREmbEN2Ae
Bella Mehta bella_mehta ( View Tweet)
Exercise does not cause objective signs of increased disease activity in PsA ⭐️11 weeks of High Intensity Interval Training in PsA pts did not show worsening changes in MRI SI joint bone marrow edema. Abs#1362 @RheumNow #ACRBest https://t.co/A3aOEy8Wz0 https://t.co/arPvjsbudm

Links:

Robert B Chao, MD doctorRBC ( View Tweet)
×